Literature DB >> 14684759

The association between magnesium intake and fasting insulin concentration in healthy middle-aged women.

Teresa T Fung1, JoAnn E Manson, Caren G Solomon, Simin Liu, Walter C Willett, Frank B Hu.   

Abstract

OBJECTIVE: We assessed the association between magnesium intake and fasting insulin levels in a large cohort of women.
METHODS: Female nurses free of diabetes, cardiovascular diseases and cancer from the Nurses Health Study provided blood samples between 1989-1990. We selected a sub-sample of 219 women for this analysis. Magnesium intake was assessed by a food frequency questionnaire in 1990 and categorized into quartiles. Cross-sectional geometric means of fasting insulin concentrations by quartiles of magnesium intake were obtained with Generalized Linear Model and adjusted for several risk factors and lifestyle characteristics.
RESULTS: After adjustment for age, body mass index (BMI), total energy, physical activity, hours per week spent sitting outside work, alcohol intake, smoking, and family history of diabetes, magnesium intake was inversely associated with fasting insulin concentration. The multivariate adjusted geometric mean for women in the lowest quartile of magnesium intake was 11.0 microU/mL and 9.3 microU/mL among those in the highest quartile of magnesium intake (p for trend = 0.04). The inverse association remained when we considered magnesium from only food sources.
CONCLUSION: Higher magnesium intake is associated with lower fasting insulin concentrations among women without diabetes. Because lower fasting insulin concentrations generally reflect greater insulin sensitivity, these findings provide a mechanism through which higher dietary magnesium intake may reduce the risk of developing type 2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14684759     DOI: 10.1080/07315724.2003.10719332

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  11 in total

1.  Maternal magnesium deficiency in mice leads to maternal metabolic dysfunction and altered lipid metabolism with fetal growth restriction.

Authors:  Madhu Gupta; Malvika H Solanki; Prodyot K Chatterjee; Xiangying Xue; Amanda Roman; Neeraj Desai; Burton Rochelson; Christine N Metz
Journal:  Mol Med       Date:  2014-08-14       Impact factor: 6.354

2.  Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies.

Authors:  Adela Hruby; Julius S Ngwa; Frida Renström; Mary K Wojczynski; Andrea Ganna; Göran Hallmans; Denise K Houston; Paul F Jacques; Stavroula Kanoni; Terho Lehtimäki; Rozenn N Lemaitre; Ani Manichaikul; Kari E North; Ioanna Ntalla; Emily Sonestedt; Toshiko Tanaka; Frank J A van Rooij; Stefania Bandinelli; Luc Djoussé; Efi Grigoriou; Ingegerd Johansson; Kurt K Lohman; James S Pankow; Olli T Raitakari; Ulf Riserus; Mary Yannakoulia; M Carola Zillikens; Neelam Hassanali; Yongmei Liu; Dariush Mozaffarian; Constantina Papoutsakis; Ann-Christine Syvänen; André G Uitterlinden; Jorma Viikari; Christopher J Groves; Albert Hofman; Lars Lind; Mark I McCarthy; Vera Mikkilä; Kenneth Mukamal; Oscar H Franco; Ingrid B Borecki; L Adrienne Cupples; George V Dedoussis; Luigi Ferrucci; Frank B Hu; Erik Ingelsson; Mika Kähönen; W H Linda Kao; Stephen B Kritchevsky; Marju Orho-Melander; Inga Prokopenko; Jerome I Rotter; David S Siscovick; Jacqueline C M Witteman; Paul W Franks; James B Meigs; Nicola M McKeown; Jennifer A Nettleton
Journal:  J Nutr       Date:  2013-01-23       Impact factor: 4.798

3.  Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease.

Authors:  Abigail May Khan; Lisa Sullivan; Elizabeth McCabe; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Am Heart J       Date:  2010-10       Impact factor: 4.749

Review 4.  Magnesium and type 2 diabetes.

Authors:  Mario Barbagallo; Ligia J Dominguez
Journal:  World J Diabetes       Date:  2015-08-25

5.  Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes.

Authors:  Dae Jung Kim; Pengcheng Xun; Kiang Liu; Catherine Loria; Kuninobu Yokota; David R Jacobs; Ka He
Journal:  Diabetes Care       Date:  2010-08-31       Impact factor: 19.112

6.  Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study.

Authors:  X Zhang; E L Giovannucci; K Wu; S A Smith-Warner; C S Fuchs; M Pollak; W C Willett; J Ma
Journal:  Br J Cancer       Date:  2012-03-13       Impact factor: 7.640

7.  Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort.

Authors:  Lijun Wu; Xiangzhu Zhu; Lei Fan; Edmond K Kabagambe; Yiqing Song; Menghua Tao; Xiaosong Zhong; Lifang Hou; Martha J Shrubsole; Jie Liu; Qi Dai
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

8.  Magnesium intake and colorectal cancer risk in the Netherlands Cohort Study.

Authors:  P A van den Brandt; K M Smits; R A Goldbohm; M P Weijenberg
Journal:  Br J Cancer       Date:  2007-02-12       Impact factor: 7.640

Review 9.  Dietary magnesium and genetic interactions in diabetes and related risk factors: a brief overview of current knowledge.

Authors:  Adela Hruby; Nicola M McKeown; Yiqing Song; Luc Djoussé
Journal:  Nutrients       Date:  2013-12-06       Impact factor: 5.717

10.  Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans.

Authors:  Adela Hruby; James B Meigs; Christopher J O'Donnell; Paul F Jacques; Nicola M McKeown
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.